Posted On: 09/17/2014 10:38:46 AM
Post# of 72445
I do miss TOB over here but understand the difficulties of keeping up across boards. Too much of a circus over there for me to join in with any 2 cents I might have.
Here's a wonderful TOB post from a few minutes ago:
"CTIX volume already above average at 9:03am CT. (9/17/2014)
Tested the prior all-time high at 2.47.
Some resistance at this level is to be expected, however, resistance is weakened by several factors.
1. The resistance printed almost 2 years ago.
2. At the time of the prior high, CTIX had just one drug beginning a trial and no near-term catalysts.
3. CTIX had already made a huge rally that year, from a low of .36 to 2.47
Now the rally is strengthened by numerous factors.
1. A key near-term catalyst approaching with Brilacidin PIIb results.
2. Trial start catalysts approaching for Prurisol, Kevetrin 1b, Brilacidin OM.
3. The percentage rise is much smaller to date, from a low of 1.49
4. Up-listing plans, financing already in place for up-coming trials, strong possibility of a partnership on positive Brilacidin PIIb results.
5. Flagship cancer drug Kevetrin is at a high dose, past the range believed therapeutic, and an almost certain successful trial primary outcome of safety.
Chart challenge.
1. Double-top at the all-time high.
2. Psychological resistance at 1.50
3. Unknown number of sellers here.
My (TOB's) view on balance:
Either we are seeing the second rally wave end here, or we will see it break higher. Unknowable as it depends on the balance between the buyers and the sellers.
A rally wave continuation, or a third rally wave up to blue-sky territory is likely, as part of the previously mentioned pre-catalyst rally.
On positive Brilacidin PIIb trial results, all technical chart bets are off. News trumps charts."
Here's a wonderful TOB post from a few minutes ago:
"CTIX volume already above average at 9:03am CT. (9/17/2014)
Tested the prior all-time high at 2.47.
Some resistance at this level is to be expected, however, resistance is weakened by several factors.
1. The resistance printed almost 2 years ago.
2. At the time of the prior high, CTIX had just one drug beginning a trial and no near-term catalysts.
3. CTIX had already made a huge rally that year, from a low of .36 to 2.47
Now the rally is strengthened by numerous factors.
1. A key near-term catalyst approaching with Brilacidin PIIb results.
2. Trial start catalysts approaching for Prurisol, Kevetrin 1b, Brilacidin OM.
3. The percentage rise is much smaller to date, from a low of 1.49
4. Up-listing plans, financing already in place for up-coming trials, strong possibility of a partnership on positive Brilacidin PIIb results.
5. Flagship cancer drug Kevetrin is at a high dose, past the range believed therapeutic, and an almost certain successful trial primary outcome of safety.
Chart challenge.
1. Double-top at the all-time high.
2. Psychological resistance at 1.50
3. Unknown number of sellers here.
My (TOB's) view on balance:
Either we are seeing the second rally wave end here, or we will see it break higher. Unknowable as it depends on the balance between the buyers and the sellers.
A rally wave continuation, or a third rally wave up to blue-sky territory is likely, as part of the previously mentioned pre-catalyst rally.
On positive Brilacidin PIIb trial results, all technical chart bets are off. News trumps charts."
(0)
(0)
